| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 12 |
| 1 | DEXAMETHASONE 1.5 MG | 12 |
| 2 | FLUDARABINE PHOSPHATE | 12 |
| 3 | LENALIDOMIDE | 11 |
| 4 | CARFILZOMIB | 10 |
| 5 | POMALIDOMIDE | 9 |
| 6 | DARATUMUMAB | 7 |
| 7 | CYCLOPHOSPHAMIDE | 6 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIFILEUCEL | 1 | 0.0035 |
| 1 | SILTUXIMAB | 1 | 0.0015 |
| 2 | MOGAMULIZUMAB-KPKC | 2 | 0.0015 |
| 3 | ALDESLEUKIN | 1 | 0.0008 |
| 4 | TALQUETAMAB-TGVS | 1 | 0.0007 |
| 5 | SELUMETINIB | 1 | 0.0006 |
| 6 | BREXUCABTAGENE AUTOLEUCEL | 1 | 0.0005 |
| 7 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 8 | CARFILZOMIB | 10 | 0.0004 |
| 9 | BELANTAMAB MAFODOTIN | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 2 | 0.0015 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 3 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 4 | CD19-directed Chimeric Antigen Receptor [EPC] | 2 | 0.0002 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 6 | Proteasome Inhibitor [EPC] | 10 | 0.0001 |
| 7 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |